Device Trial Radar · NCT04510558
Reducing the Incidence of Incisional Hernia After Stoma Closure Using a Prophylactic Mesh
Last checked: Nov 19, 2026Latest source record: Sep 13, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
72
Planned (sponsor's estimate)
Start
May 1, 2021
Primary completion
May 2024
Study completion Dec 2024
Sponsor
- Lead sponsor
- University Hospital, GenevaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 12, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Prevention
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Background: Preliminary studies have shown that application of a prophylactic mesh during stoma closure reduces the incidence of incisional hernia at site of stoma closure. Methods/Design: The study will be a randomized controlled single-blinded monocentric study determining the 1-year incidence of incisional hernia in cancer patients undergoing ileostomy or colostomy closure with or without prophylactic non-absorbable mesh applied in the sublay position. Discussion: Prevention of incisional hernia at site of stoma closure will lead to an improvement in patients' quality of life and generating savings for healthcare systems. To date, no randomized controlled trial assessing the effect of prophylactic mesh applied during stoma closure on the prevention of incisional hernia has been published. With the present randomized controlled trial, we expect to demonstrate that the application of a prophylactic mesh reduces the one-year incidence of incisional hernia at site of stoma closure.
Conditions
- Incisional Hernia
Interventions
Stoma closure with non-resorbable mesh (ULTRAPRO Advanced Mesh, Ethicon, Johnson & Johnson) in the sublay positionDevice
* Antibioprophylaxis using cefuroxime and metronidazole * Standard disinfection and sterile draping * Circular incision around the stoma using the scalpel blade * Dissection around the stoma until entering the abdominal cavity * Closure of the stoma using a linear stapler * A midline laparotomy may be performed or not * Realization of an extra-corporeal or intra-corporeal side-to-side handsewn anastomosis * Closure of the posterior aponeurosis using separate Maxon 2-0 stitches * Application of an ULTRAPRO Advanced Mesh, Ethicon, Johnson \& Johnson, with +2cm on the edges, secured by 4 stiches of Maxon 2-0 * Closure of the anterior aponeurosis using separate Maxon 2-0 stitches * No subcutaneous stitches * Partial purse string skin closure using Monocryl 3-0 * Standard wound dressing
Stoma closure without meshProcedure
* Antibioprophylaxis using cefuroxime and metronidazole * Standard disinfection and sterile draping * Circular incision around the stoma using the scalpel blade * Dissection around the stoma until entering the abdominal cavity * Closure of the stoma using a linear stapler * A midline laparotomy may be performed or not * Realization of an extra-corporeal or intra-corporeal side-to-side handsewn anastomosis * Closure of the posterior aponeurosis using separate Maxon 2-0 stitches * Closure of the anterior aponeurosis using separate Maxon 2-0 stitches * No subcutaneous stitches * Partial purse string skin closure using Monocryl 3-0 * Standard wound dressing
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of incisional hernia at site of stoma at one year after closureTime frame: At one year after stoma closure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University Hospitals of Geneva
Geneva, Switzerland · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.